Breast Cancer

Pink ribbons came out of the woodwork when I was diagnosed with breast cancer, and at first, I hated them.

Two-time cancer survivor says lets look death and dying in the face so we don't live our lives in (as much) fear.

It is important to consider quality of life and survival calculations when treating older patients with HER2-positive or triple-negative breast cancer (TNBC), according to a recent talk at the 2017 Lynn Sage Breast Cancer Symposium.

Nature has provided medicine for many ailments. A male breast cancer survivor asks, why not this one?

Genomic testing is often expensive and inaccessible to those who can't afford the costs, but companies are working diligently to provide people with alternatives.

Blogging for CURE helped me find my voice and process my breast cancer experience.

At one time, the word “cancer” was only whispered and never spoken out loud. Times change, but sometimes it’s hard to let those you work with know that you have/had cancer.

Martha Carlson talks about what it's like to join a group of active advocates for stage 4 breast cancer

An optimistic attitude is beneficial to achieving good health. Those affected by cancer need to learn to tap into the valuable resource of positive self-talk. Here's how:

An injured cancer survivor reluctantly but gratefully copes with neuropathy, osteopenia and stiff-joint cancer side effects after recently breaking her foot and getting surgery.

A former Disney cast member and cancer survivor discovers a new meaning to these beloved lyrics.

A breast cancer and melanoma survivor offers ideas to help newly diagnosed cancer patients cope and get through their cancer.

One breast cancer survivor learns to finally accept breast cancer awareness month.

Women with ovarian or breast cancer often don’t receive the genetic testing they need in order to devise the best treatment plans, a new study says.

It's hard to watch someone choose to end or forgo conventional treatment without succumbing to the urge to educate. But education isn't always what patients need.

With summer over, two-time cancer survivor and clutter-clearing author shares time management help with a cancer-enhanced awareness that her time is her life.

Research announced at the Madrid conference could radically change treatment for lung cancer, melanoma and kidney cancer

Extended use of aromatase inhibitors (AIs) in early breast cancer is associated with an increased risk of cardiovascular events and bone fractures, according to results from a study published in the Journal of the National Cancer Institute.

Can a class of drugs commonly prescribed to help lower cholesterol levels protect against breast cancer?

Women with breast cancer who are positive for the BRCA gene mutation may be more likely to encounter difficulty with fertility preservation compared to women with breast cancer who have tested negative for the BRCA mutation.

Nausea and vomiting are no longer top concerns for patients undergoing chemotherapy. Socio-psychological concerns, instead, have jumped to the forefront.

Women want bilateral mastectomy more often, and many are getting it.

Be prepared. After cancer, other medical issues can trigger outsized emotional responses.

It's been said that reaching the ten-year mark means you are home free. But are you?

Up-and-coming treatments for patients with triple-negative breast cancer (TNBC) may include immunotherapy combinations, according to Sylvia Adams, M.D.

As unpredictable as the weather, the cycle of cancer is often difficult to forecast.

If I’d known I would forget so easily, I would have snapped a photo. I could have easily locked the photo away for safe keeping. When I got the urge to remember, I could have pulled out the photo and looked, but would that have really been a good thing?

A breast cancer and melanoma survivor who also speaks and writes about clutter clearing shares some cancer clutter clearing tips.

Stress reduction is a vital part of breast cancer survivorship. Learn how one survivor incorporated the word

There is a relationship between the genetics of BRCA1 and BRCA2 mutations and the risk of a patient with breast or ovarian cancer being resistant to platinum-based chemotherapy, according to recent research conducted at the Perelman School of Medicine at the University of Pennsylvania. The study’s senior author Katherine Nathanson, M.D., spoke with CURE about these findings.